Business & Finance

Genomics company reports first quarter net loss of $16.7 million

Published in AIDS Weekly, November 21st, 2005

Celera Genomics Group (CRA), an Applera Corp. business, reported a net loss of $16.7 million, or $0.23 per share, for the first quarter of fiscal 2006 ended September 30, 2005, compared to a net loss of $20.3 million, or $0.28 per share, for the first quarter of fiscal 2005.

The first-quarter fiscal-2006 results included a $4.5 million pretax gain from the sale of an investment. The first-quarter fiscal-2005 results included a $4.5 million pretax charge related to the discontinuation of most of the operations of Paracel. All per share amounts refer to Applera Corp.-Celera Genomics Group common stock.

"Celera Genomics made notable progress during the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-11-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry